WALENSKY LOREN D has a total of 13 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are WALLACH DAVID, NYMOX PHARMACEUTICAL CORP and MEDIGENE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Walensky Loren D | 13 |
#2 | Korsmeyer Stanley J | 4 |
#3 | Verdine Gregory | 3 |
#4 | Bird Gregory H | 3 |
#5 | Bird Gregory | 3 |
#6 | Stewart Michelle L | 2 |
#7 | Wade Mark | 1 |
#8 | Cohen Nicole | 1 |
#9 | Bernal Federico | 1 |
#10 | Carrasco Ruben | 1 |
Publication | Filing date | Title |
---|---|---|
US2013035304A1 | Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |